broad base growth result guidanc ahead expect
maintain market perform rate stryker corpor follow last
week releas result continu deliv revenu growth
high end large-cap med-tech sector post anoth solid quarter
sale earn growth organ growth came ex one less
sell day adjust ep grew ahead consensu
exceed guidanc
despit anoth strong show current trade
ep estim versu consensu orthoped peer zimmer biomet
hold mo pt slightli averag group select
large-cap med-tech peer base profil think share remain fairli
valu current level
total sale bln y/i cc organ versu
consensu bln standout perform quarter includ
neurotechnolog spine driven growth neurovascular medsurg
benefit double-digit growth endoscopi less posit note neg
price impact growth howev trauma sale growth strong
knee continu driven mako result includ growth
increas volum price headwind
guidanc adjust top bottom line call organ
top-lin growth adjust ep y/i
favor fx impact current rate remain unchang previou
guidanc set organ sale growth ep
impact fx
turn compani segment ortho increas y/i cc
 knee cc hip cc trauma extrem
cc medsurg increas y/i cc
instrument cc endoscopi cc medic cc sustain
cc neurotech spine increas y/i cc
 driven neurotech cc spine cc
focus orthoped segment exceed expect bln
sale y/i organ growth continu mid-to-high single-
digit growth trend past sever quarter compani report
progress mako robot demand continu tka knee platform
mako instal total quarter ou compar
upgrad robot field tka track reach
end expect complet vast major
thomson reuter jmp secur llc
compani report jmp secur llc
report read conjunct import disclosur inform includ attest regul analyst certif
approxim surgeon train mako tka
procedur perform quarter nearli hospit hospit
orthoped practic mako robot today
notabl point call includ appar slowdown larg joint
reconstruct market sequenti result still peer notic
deceler last quarter ortho soft eu due bed blockag uk
report soft spine market pedicl screw double-digit price declin
core spinal product line strong start entellu acquisit close march
manag updat guidanc includ sell day variat ep expect
follow figur outlin key metric organ sale expect
previous ep set previous
figur follow page contain comparison actual result jmp estim rang
revenu metric along select commentari
guidancecurrentpriordirectioncommentsrevenu sell day compar number day current level time earn calladj stryker corpor
 bpslarg joint bpstrauma bpssustain bpsneuro bpstotal blnannual bpsgross bpsup bp y/i favor impact product effici fx gain off-set mix bpsdown bp y/i reflect continu focu oper expens improv ctg program off-set neg impact acquisit continu plan invest ctg program project invest bpsdown bp mln bpsoper bpstax bpsoper tax rate off-set higher-than-expect benefit relat stock compens expensenet sale qtr cc growth cc exclud acquisit volum price cc neurovascular growth due strength hemorrhag ischem stroke entellu good start close march cc low double-digit price declin across portfolio exclud tritanium implant experienc soft core sale qtr constant currenc volum price cc growth cc total robot instal ou upgrad tka reach end vast major expect upgrad robot instal competitv account surgeon train train util roughli cc product foot ankl portfolio call perform sale qtr cc cc exclud acquisit volum price cc organ growth includ neg impact suppli issu relat puerto rico facil ramp-up power tool busi double-digit growth led micropow cc strong double-digit growth core busi posit perform novadaq state integr go well close cc core bed power cot physio product strong medic busi cotinu recov last year product issu back market complet product portfolio cc stryker corpor
one largest compani med-tech year busi develop activ given compani evolv footprint
span well beyond tradit orthoped line three major sale segment today orthopaed hip knee trauma medsurg
instrument endoscopi medic reprocess neurotech spine neurosurg neurovascular devic tradit metal
implant orthobiolog mainli spine fusion divis complement nice also offer signific divers
multipl way grow grant compani potenti remain balanc time ideal benefit abil off-set
under-perform line stronger devic sale adjac arena
highli diversifi bring posit neg consequ depend upon underli fundament differ
market volum rebound core orthoped arena may occur would like mute impact growth given
sizabl revenu base price like remain headwind across sector med-tech could worsen new product may perform
well anticip acquisit integr could prove challeng expect signific exposur outsid
ou sale meaning exposur europ asia subject compani headwind tailwind may aris
geographi
research analyst prepar report does/do herebi certifi view present report accord my/our
person view secur issuer discuss report mandat sec regul ac part my/our compens
directli indirectli relat specif view recommend express herein certif made
oblig set forth sec regul ac person entiti may use purpos certif made base
my/our analysi date report public i/w assum oblig updat certif reflect fact circumst
event may subsequ come my/our attent sign david turkali daniel stauder
